Renal transplantation in systemic vasculitis: when is it safe?

Mark Little, B Hassan, Steven Jacques, D Game, E Salisbury, AE Courtney, C Brown, AD Salama, Lorraine Harper

Research output: Contribution to journalArticle

52 Citations (Scopus)


Background. There are no clear guidelines on renal transplantation in patients with antineutrophil cytoplasmic antibody (ANCA)-positive vasculitis. Methods. We undertook a survey of transplant centres across Europe to assess whether there was consensus about how to manage transplantation in patients with vasculitis. We then identified 107 renal allograft recipients whose primary disease was systemic vasculitis and assessed their outcome post-transplant. Results. All questionnaire respondents felt that vasculitis should be in remission at transplantation, 16% believed that ANCA should be negative pre-transplant and 40% felt that one should wait >12 months after remission before transplanting. Remission was defined by all as an absence of clinical symptoms of vasculitis, but three respondents (13%) also required a negative ANCA test. Overall graft survival was 70% after 10 years (95% C.I. 58-82). A total of 30 (41% of those with known ANCA status) were ANCA-positive peri-transplantation, while 15 (14%) were transplanted
Original languageEnglish
Pages (from-to)3219-3225
Number of pages7
JournalNephrology, Dialysis, Transplantation
Issue number10
Publication statusPublished - 1 Oct 2009


  • vasculopathy
  • transplantation
  • survey
  • vasculitis
  • ANCA


Dive into the research topics of 'Renal transplantation in systemic vasculitis: when is it safe?'. Together they form a unique fingerprint.

Cite this